Drugmaker&#39;s stocks fall after FDA researcher wonders about 5 drugs
88351
Dr David Graham told a Senate panel that five well known drugs, which are currently on the market, needed to be looked at more closely - this sent share values down for many drug companies.
730207
NEW YORK -- The stock of Ivax Corp., a maker of generic drugs, fell to a 52-week low Monday after the company said competitive pricing hurt its third-quarter results, causing them to fall short of Wall Street&#39;s expectations.
560123
US stocks fell on Friday dragged down by a string of negative reports from drug makers, with Pfizer Inc. (PFE.N: Quote, Profile, Research) , AstraZeneca Plc.
718380
Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon.
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
535061
Stocks fell on Friday, led by  pharmaceutical shares after a U.S. health official raised  concerns about drug safety and a drop in chip-equipment makers  following a ratings downgrade by Goldman Sachs.
428503
An FDA official named and shamed several drugs offered by major drugs companies, causing their shares to fall sharply in early trading.
321307
Shares of Isis Pharmaceuticals Inc. fell after the drug company said that it won&#39;t pursue further efforts to commercialize its antisense drug alicaforsen for the treatment of Crohn&#39;s disease after late-stage
275318
Shares of Merck &amp; Co. (MRK.N: Quote, Profile, Research) fell on Thursday after a US study suggested that patients taking its Vioxx arthritis drug had a 50 percent greater risk
105959
Shares of the Medicines Co.  fell 10 percent on Monday after the U.S. Congress failed to enact a bill that would have helped the company's bid to extend a patent on its flagship drug Angiomax, a blood thinner.
131381
Uncertainty is spreading like a cancer in the pharmaceutical investing world, and that&#39;s bad news for the segment&#39;s kingpin, Pfizer (NYSE: PFE).
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
81475
Stocks were knocked lower on Thursday  as investors worried that rising prices for oil and commodities  would shrink corporate profits, while drug shares fell on  possible stricter scrutiny from regulators.
244370
U.S. stocks fell on Friday dragged  down by a string of negative reports from drug makers, with  Pfizer Inc. PFE.N, AstraZeneca Plc. AZN.L and Eli Lilly and  Co. LLY.N delivering bad news about key products.
238512
Shares of Pfizer Inc., the world's largest drugmaker, sank Monday on news that the company had halted development of a key new cholesterol treatment that was heralded as its engine for future growth as the company struggles with stagnant sales.
414238
Stocks inched lower on Friday,  pressured by a sharp drop in Pfizer Inc. PFE.N after the drug  maker said patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
384648
A warning by the regulator who spearheaded investigations into Vioxx that five further drugs may have safety concerns has prompted a plunge in shares in major pharmaceuticals companies.